Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Studying Youth Well-Being Through Minecraft Digital Construction: A Visual and Thematic Study.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine·2025
Same author

Prevalence, characteristics and management of migraine patients with triptan failure in primary care: the EMR France-Mig study.

The journal of headache and pain·2025
Same author

A slobbering appendix.

Acta gastro-enterologica Belgica·2025
Same author

[Alphavirus derived vector, still a relevant system through new mobilisation procedure].

Virologie (Montrouge, France)·2022
Same author

Zinc and cadmium accumulation in controlled crosses between metallicolous and nonmetallicolous populations of Thlaspi caerulescens (Brassicaceae).

The New phytologist·2021
Same author

A rare BRAF T599dup mutation conferring sensitivity to BRAF inhibitor in a patient with metastatic melanoma.

The British journal of dermatology·2018
Same journal

[From rhizomania to viral RNAs structure functions].

Virologie (Montrouge, France)·2026
Same journal

[Characteristics of viral gastroenteritis in solid organ transplant patients].

Virologie (Montrouge, France)·2026
Same journal

[ResaFlu/FluResearchNet International symposium,Toulouse, November 26-27, 2025].

Virologie (Montrouge, France)·2026
Same journal

[ViRAE 2025: a landmark inaugural edition for virology at INRAE].

Virologie (Montrouge, France)·2026
Same journal

[13<sup>rd</sup> Cytokines annual meeting, Novembre 2-5 2025, Seattle, USA].

Virologie (Montrouge, France)·2026
Same journal

[Annual report of the French Society for Virology].

Virologie (Montrouge, France)·2026
See all related articles

Related Experiment Video

Updated: Aug 27, 2025

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
08:46

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Published on: May 24, 2012

36.3K

[Lentiviral vectors].

C Collin1, J-C Pagès1

  • 1Inserm U 966, université François-Rabelais de Tours, faculté de médecine, 10, bd Tonnellé, 37000 Tours; Service de biochimie et biologie moléculaire, hôpital Trousseau, CHRU de Tours, 37044 Tours.

Virologie (Montrouge, France)
|September 24, 2022
PubMed
Summary
This summary is machine-generated.

Lentiviral vectors offer stable in vivo gene transfer, overcoming limitations of older retroviral vectors. Their development and safety profile make them promising for clinical gene therapy applications.

Keywords:
biosafetylentivirusretrovirusvector

More Related Videos

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
11:08

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

35.5K
Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector&#45;Mediated Gene Manipulation
06:33

Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector-Mediated Gene Manipulation

Published on: February 16, 2024

1.4K

Related Experiment Videos

Last Updated: Aug 27, 2025

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
08:46

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Published on: May 24, 2012

36.3K
Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
11:08

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

35.5K
Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector&#45;Mediated Gene Manipulation
06:33

Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector-Mediated Gene Manipulation

Published on: February 16, 2024

1.4K

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Virology

Context:

  • RNA interference (RNAi) has increased interest in lentiviral vectors.
  • Adverse effects with oncoretroviral vectors highlighted the need for safer gene transfer tools.
  • Lentivectors were developed in 1996 to improve transduction of non-dividing cells.

Purpose:

  • To review lentiviral vectors, emphasizing their advantages over oncoretroviral vectors.
  • To highlight the specific features that make lentiviral vectors suitable for clinical gene delivery.
  • To discuss the evolution and current status of lentiviral vector technology.

Summary:

  • Lentiviral vectors have evolved significantly since their inception, becoming a popular and efficient gene transfer tool.
  • They offer stable in vivo gene transfer, a critical requirement for therapeutic applications.
  • Commercial solutions are now available, reflecting their maturity and utility.

Impact:

  • Lentiviral vectors are strong candidates for the safe and effective clinical delivery of therapeutic genes.
  • Their improved efficiency and safety profile address key challenges in gene therapy.
  • This technology has the potential to advance treatments for various genetic disorders.